Dr. Habil Khorakiwala founded Wockhardt in 1967. He has gone on to build a multinational enterprise active in the fields of pharmaceuticals, biotechnology and hospitals and created one of India’s leading healthcare businesses.
As well as being a highly successful entrepreneur he has held many senior positions as an industry representative and is highly respected in India and overseas. As a former president of FICCI (Federation of Indian Chambers of Commerce & Industry) Dr. Khorakiwala represented India’s business interests to many presidents, prime ministers and heads-of-state.
He is currently the Chairman of the Board of Governors at the Centre for Organisation & Development in Hyderabad, a non-profit scientific and industrial research organisation, and a recognised doctoral research centre.
A Harvard alumni, Dr. Habil Khorakiwala is a member of the World Economic Forum and was a distinguished speaker at its 2008 Davos meeting. A graduate of Purdue University in the US, in 2010 he was awarded an honorary doctorate by his alma mater.
He has served as the Honorary Consul General of Sweden in Mumbai.
Dr. Murtaza Khorakiwala graduated in medicine from GS Medical College, Mumbai. He holds an MBA degree from the University of Illinois, USA.
Dr. Khorakiwala is the Managing Director of Wockhardt Ltd. since April 2009. His young and dynamic leadership has become an ideal springboard for various corporate initiatives in creating a New Wockhardt.
A member of the executive committee of the Indian Pharmaceutical Association (IPA), he was the Past Chairman of the Marketing Committee of the Bombay Management Association.
Mr. Huzaifa Khorakiwala is a Bachelor of Commerce graduate from Mumbai University. He holds a Masters degree in Business Management from Yale University School of Management, USA.He joined the company in July 1996 and over the years has run various Wockhardt businesses and served in Corporate Administration.
Dr. Huzaifa Khorakiwala devotes a significant part of his time to Wockhardt’s corporate social responsibility activities. He serves as CEO of the Wockhardt Foundation.
Sirjiwan became a part of Wockhardt during the acquisition of Merind in 1998 and was actively involved in the post-acquisition, integration and rationalisation with the parent Company. A Post Graduate in Pharmacy and Management, Sirjiwan was appointed as General Manager, Contract Manufacturing in 2002.
After the acquisition of C P Pharmaceuticals Ltd. he was posted in UK as Managing Director of Wockhardt UK Limited, combined entity established from the integration of C P Pharmaceuticals and Wallis Laboratories in the United Kingdom. Since 2003 he has played a key role in restructuring the product portfolio and and expanding the business in the the UK.
Sirjiwan was given additional responsibility of overseeing the Irish business of Pinewood Laboratories Ireland in 2009 after the acquisition Pinewood Laboratories in October 2006. As Managing Director of Wockhardt UK , Pinewood and rest of the Europe , he is responsible for growing the business in these regions through strategic implementations of business initiatives across the sales, marketing, manufacturing and operation functions.
Sirjiwan Singh has built a robust business for these regions by exploring alliances ,tapping new business opportunities and optimising the operations of the manufacturing facilites in the UK and Ireland. He has also played a major role in due diligence , acquisitions and integrations of various companies into the Wockhardt Group.
Manas Datta brings with him a rich experience of 25 years in several areas like Corporate Finance, Accounting, Mergers & Acquisition, Treasury etc. He has spearheaded finance and accounting functions in his career. Manas is a Cost Accountant and an Alumnus of IIM(A).
In March 2016, Manas has been conferred with "Role of Honour for CFO 100" for exceptional calibre and contribution to the world of finance by CFO India and “Most Influential CFOs of India” by Chartered Institute of Management Accountants (CIMA) in June 2016.
Sunil Khera joined Wockhardt in January 2006 as President - Domestic Business and later was entrusted with an additional responsibility of handling the Emerging Markets and RoW business.
He is currently focusing his full attention in managing the Americas business (includes the US, Canada & Lat-Am countries).
Dr. Jayant Karajgi is the Chief Scientific Officer – Pharma Research, who brings a very varied and rich experience of over 25 years, of which 7 years has been in the USA and 18 years in India in the areas of Pharma Research across various dosage forms like oral solids, injectables, ophthalmic, oral liquids, softgels, nasal, oncology, hormones, differentiated generics, complex injectables etc.
Dr. Karajgi is a University Gold Medalist in B.Pharm and M.Pharm; and he has earned his PhD in Pharmaceutical Technology.
Sanjeev Mehta has being with Wockhardt for the past 25 years and has grown along with the organisation.
His efforts have fructified in creating an end-to-end global supply chain for Wockhardt, which is a benchmark in the pharma industry. He has successfully implemented SAP in supply chain, which tracks on-line sales, service levels and product availability. He has also played a pivotal role in integrating the supply chain network of acquired companies seamlessly with the parent company.
Sanjeev also manages the India Generic and API businesses for Wockhardt.
Mr. Anjani Kumar, President, Operations, leads the Manufacturing, Quality and compliance teams of formulations, biotech and API facilities in India. In addition, he also oversees the upcoming facility in Dubai. Anjani brings over 30 years of rich experience in the pharmaceutical industry.
Before joining us, Anjani worked with Cipla for 29 years and Lupin for 3 years. In his last assignment at Cipla, Anjani managed over 30 manufacturing units across India and overseas. He has successfully handled various regulatory inspections (more than 20 USFDA audits, 20 MHRA & 30 WHO inspections) and many without 483 citations during his 29 year tenure with Cipla.
Anjani brings a significant expertise to the table in areas of manufacturing, quality, engineering, OHSE and projects. He has been mandated to further strengthen our “Right, First Time” focus; while keeping the operations team ahead of learning curve.
Ajay Sahni joined Wockhardt in February 2007 and brings with him around 23 years of pharmaceutical work experience in the areas of Business Development (M&A), Strategic Planning and Regional Finance Management.
He is currently managing the European hub office in Switzerland and also overlooks the Negma operations in France.
With an experience spanning multi-cultural environments in the US, Europe and SE Asia, Ajay is adept at bridging language and cultures in alignment with the Company ethos.
Prem Singh is a graduate in Mechanical Engineering and a Post Graduate in Management from IIT Delhi and he brings with him a rich experience of 24 years.
In addition to his rich experience in HR, he has also got significant experience in business areas like Six Sigma, TQM, Customer Satisfaction Surveys etc. He is a certified Black Belt in Six Sigma. He is also a Trainer accredited with All India Management Association
Prem has also been a winner of Global HR Excellence Award for his contribution in developing a high performance work culture at Owens Corning India Ltd.
Venkat Iyer joined Wockhardt in November 2011. He has a Masters in Business Administration from South Gujarat University and a Masters in Information Systems from University of Bridgeport (USA).
Venkat has a clear mandate to leverage Medical IT Technology as a distinctive differentiator for Wockhardt. All IT teams across Wockhardt businesses around the globe report to Venkat.